EYES a stock that can help people SEE again is $2 DOWN from $9
Like i said they sold short and now THEY tell everyone they are going to INVEST but all they did was sell at $9 and buy back at $2 making $7 X how many shares naked shorted == MILLIONS of profit
|
Issuer:
|
Second Sight Medical Products, Inc.
|
|
| Expected Offering: |
Up to approximately $7.5 million of Common Stock (including over-allotment option)
|
|
|
Listing:
|
NASDAQ: EYES
|
|
|
Over-Allotment Option:
|
15% (100% Primary)
|
|
|
Expected Pricing Date:
|
Thursday, April 30th
|
|
|
Sole Book-Runner:
|
ThinkEquity, a division of Fordham Financial Management, Inc.
|
|
|
Business Summary:
|
Second Sight Medical Products, Inc., was founded to manufacture and market implantable visual prosthetics intended to deliver useful artificial vision to blind individuals. Leveraging its 20 years of experience in neuromodulation for vision, Second Sight developed the Orion® Visual Cortical Prosthesis System (“Orion”), an implanted cortical stimulation device intended to provide useful artificial vision to individuals who are blind due to a wide range of causes, including retinitis pigmentosa (“RP”), glaucoma, diabetic retinopathy, optic nerve injury or disease and eye injury. Orion is intended to convert images captured by a miniature video camera mounted on glasses into a series of small electrical pulses. The device is designed to bypass diseased or injured eye anatomy and to transmit these electrical pulses wirelessly to an array of electrodes implanted on the surface of the brain’s visual cortex, where it is intended to provide the perception of patterns of light.
|
|
Comment: Anonymous submission from an Alert Reader.
